ZNF320

gene
On this page

Also known as ZFPLDKFZp686G16228

Summary

ZNF320 (zinc finger protein 320, HGNC:13842) is a protein-coding gene on chromosome 19q13.41, encoding Zinc finger protein 320 (A2RRD8). May be involved in transcriptional regulation.

ZNF320 encodes a Kruppel-like zinc finger protein. Members of this protein family are involved in activation or repression of transcription.

Source: NCBI Gene 162967 — RefSeq curated summary.

At a glance

  • GWAS associations: 3
  • Clinical variants (ClinVar): 74 total
  • MANE Select transcript: NM_001351774

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:13842
Approved symbolZNF320
Namezinc finger protein 320
Location19q13.41
Locus typegene with protein product
StatusApproved
AliasesZFPL, DKFZp686G16228
Ensembl geneENSG00000182986
Ensembl biotypeprotein_coding
OMIM606427
Entrez162967

Gene structure

Transcript identifiers

Ensembl transcripts: 34 — 27 protein_coding, 6 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay

ENST00000391781, ENST00000593618, ENST00000594408, ENST00000594741, ENST00000595202, ENST00000595635, ENST00000596215, ENST00000597091, ENST00000597111, ENST00000597265, ENST00000597856, ENST00000598199, ENST00000600930, ENST00000601334, ENST00000673631, ENST00000682928, ENST00000855873, ENST00000855874, ENST00000855875, ENST00000855876, ENST00000855877, ENST00000855878, ENST00000855879, ENST00000919701, ENST00000919702, ENST00000919703, ENST00000919704, ENST00000919705, ENST00000919706, ENST00000919707, ENST00000919708, ENST00000919709, ENST00000919710, ENST00000952398

RefSeq mRNA: 14 — MANE Select: NM_001351774 NM_001351773, NM_001351774, NM_001351775, NM_001351776, NM_001351777, NM_001387570, NM_001387571, NM_001387572, NM_001387573, NM_001387574, NM_001387575, NM_001387576, NM_001387577, NM_207333

CCDS: CCDS33095, CCDS92678

Canonical transcript exons

ENST00000682928 — 6 exons

ExonStartEnd
ENSE000031670465289752052897635
ENSE000031736985289122952891346
ENSE000031738615289377952893856
ENSE000032262475287618052881983
ENSE000037962575289024152890328
ENSE000038962645288812752888253

Expression profiles

Bgee: expression breadth ubiquitous, 239 present calls, max score 97.94.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 10.1599 / max 149.6492, expressed in 1584 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
18253710.15991584

Top tissues by expression

245 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
buccal mucosa cellCL:000233697.94gold quality
oviduct epitheliumUBERON:000480496.30gold quality
pancreatic ductal cellCL:000207992.93gold quality
tendon of biceps brachiiUBERON:000818889.76gold quality
endometriumUBERON:000129589.28gold quality
right uterine tubeUBERON:000130288.95gold quality
epithelial cell of pancreasCL:000008388.64gold quality
metanephros cortexUBERON:001053387.23gold quality
germinal epithelium of ovaryUBERON:000130487.12gold quality
fallopian tubeUBERON:000388986.79gold quality
ganglionic eminenceUBERON:000402386.75gold quality
cortical plateUBERON:000534386.60gold quality
endothelial cellCL:000011586.56gold quality
right hemisphere of cerebellumUBERON:001489085.95gold quality
colonic epitheliumUBERON:000039785.89gold quality
cerebellar hemisphereUBERON:000224585.72gold quality
stromal cell of endometriumCL:000225585.65gold quality
cerebellar cortexUBERON:000212985.49gold quality
uterusUBERON:000099585.20gold quality
ovaryUBERON:000099285.06gold quality
body of uterusUBERON:000985384.99gold quality
right ovaryUBERON:000211884.80gold quality
body of pancreasUBERON:000115084.75gold quality
left ovaryUBERON:000211984.63gold quality
islet of LangerhansUBERON:000000684.57gold quality
urinary bladderUBERON:000125584.51gold quality
cerebellumUBERON:000203784.51gold quality
pancreasUBERON:000126484.48gold quality
ileal mucosaUBERON:000033184.43gold quality
female reproductive systemUBERON:000047484.36gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no4.26

Regulation

Is transcription factor: yes

JASPAR motifs

MotifNameFamily
MA1976.1ZNF320More than 3 adjacent zinc fingers
MA1976.2ZNF320More than 3 adjacent zinc fingers
MA1976.3ZNF320More than 3 adjacent zinc fingers

JASPAR matrix evidence (PMIDs): PMID:28273063

miRNA regulators (miRDB)

123 targeting ZNF320, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3646100.0073.565283
HSA-MIR-3924100.0072.092394
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-548AW99.9972.573559
HSA-MIR-371B-5P99.9975.344759
HSA-MIR-186-5P99.9970.833707
HSA-MIR-548C-3P99.9974.017587
HSA-MIR-477599.9875.006394
HSA-MIR-480399.9871.993117
HSA-MIR-19A-3P99.9875.332762
HSA-MIR-19B-3P99.9875.442754
HSA-MIR-3692-3P99.9870.272139
HSA-MIR-373-5P99.9875.364753
HSA-MIR-616-5P99.9875.584775
HSA-MIR-1213699.9872.815713
HSA-MIR-548P99.9872.253784
HSA-MIR-590-3P99.9674.346478
HSA-MIR-1468-3P99.9672.743797
HSA-MIR-6778-3P99.9667.292693
HSA-MIR-6508-5P99.9270.672465
HSA-MIR-568099.9169.833421
HSA-MIR-95-5P99.8972.173973
HSA-MIR-3065-3P99.8770.251407
HSA-MIR-391999.8769.452489
HSA-MIR-579-3P99.8671.663628
HSA-MIR-806799.8669.592260
HSA-MIR-5582-3P99.8672.484221
HSA-MIR-4728-5P99.8569.394718
HSA-MIR-664B-3P99.8471.653590
HSA-MIR-684499.8270.692423

Literature-anchored findings (GeneRIF, showing 1)

  • ZNF320 is a hypomethylated prognostic biomarker involved in immune infiltration of hepatocellular carcinoma and associated with cell cycle. (PMID:36287187)

Cross-species orthologs

0 orthologs

Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631)

Protein

Protein identifiers

Zinc finger protein 320A2RRD8 (reviewed: A2RRD8)

All UniProt accessions (7): A0A669KBJ2, A2RRD8, M0QX96, M0QZA2, M0R0Z8, M0R1K6, M0R2L4

UniProt curated annotations — full annotation on UniProt →

Function. May be involved in transcriptional regulation.

Subcellular location. Nucleus.

Tissue specificity. Expressed at high levels in placenta, pancreas, kidney and heart, and at lower levels in liver, skeletal muscle and brain.

Disease relevance. A chromosomal aberration involving ZNF320 is found in a form of glioblastoma. Translocation t(10;19)(q26;q13.3) with BRWD2/WDR11.

Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.

RefSeq proteins (14): NP_001338702, NP_001338703, NP_001338704, NP_001338705, NP_001338706, NP_001374499, NP_001374500, NP_001374501, NP_001374502, NP_001374503, NP_001374504, NP_001374505, NP_001374506, NP_997216 (=MANE)

Domains & families (InterPro)

IDNameType
IPR001909KRABDomain
IPR013087Znf_C2H2_typeDomain
IPR036051KRAB_dom_sfHomologous_superfamily
IPR036236Znf_C2H2_sfHomologous_superfamily
IPR050589Ikaros_C2H2-ZFFamily

Pfam: PF00096, PF01352

UniProt features (14 total): zinc finger region 12, chain 1, domain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-A2RRD8-F169.030.15

Function

Pathways and Gene Ontology

Reactome pathways

2 pathways

IDPathway
R-HSA-212436Generic Transcription Pathway
R-HSA-9843940Regulation of endogenous retroelements by KRAB-ZFP proteins

MSigDB gene sets: 41 (showing top): GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_UP, BASAKI_YBX1_TARGETS_DN, GEORGES_TARGETS_OF_MIR192_AND_MIR215, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, E2F2_TARGET_GENES, NFE2L1_TARGET_GENES, NFKBIA_TARGET_GENES, ZNF407_TARGET_GENES, MIR3646, MIR19A_3P, MIR19B_3P, MIR513A_3P_MIR513C_3P, MIR3133

GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)

GO Molecular Function (6): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)

GO Cellular Component (1): nucleus (GO:0005634)

Reactome top-level categories

Rollup of top-2 pathways:

CategoryPathways
RNA Polymerase II Transcription1
Regulation of endogenous retroelements1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
RNA polymerase II transcription regulatory region sequence-specific DNA binding2
regulation of DNA-templated transcription1
transcription by RNA polymerase II1
DNA-templated transcription1
regulation of gene expression1
regulation of RNA biosynthetic process1
cis-regulatory region sequence-specific DNA binding1
chromatin1
DNA-binding transcription factor activity1
regulation of transcription by RNA polymerase II1
transition metal ion binding1
nucleic acid binding1
binding1
cation binding1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

538 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ZNF320DMBT1Q9UGM3825
ZNF320PLAC8L1A1L4L8432
ZNF320LGALS16A8MUM7426
ZNF320MYEOVQ96EZ4382
ZNF320CLCQ05315351
ZNF320RNFT2Q96EX2324
ZNF320KRTAP3-3Q9BYR6316
ZNF320C9JR48C9JR48305
ZNF320TCEAL9Q9UHQ7296
ZNF320ERICH1Q86X53291
ZNF320TTC5Q8N0Z6290
ZNF320ENKURQ8TC29280
ZNF320MRPS25P82663278
ZNF320MRPS9P82933276
ZNF320RPL7L1Q6DKI1272

IntAct

32 interactions, top by confidence:

ABTypeScore
ZNF320KRTAP10-5psi-mi:“MI:0915”(physical association)0.560
KRTAP10-7ZNF320psi-mi:“MI:0915”(physical association)0.560
KRTAP10-5ZNF320psi-mi:“MI:0915”(physical association)0.560
TRIM28ZNF320psi-mi:“MI:0914”(association)0.530
TRIM28ZNF320psi-mi:“MI:0914”(association)0.350
ZNF320PPM1Gpsi-mi:“MI:0914”(association)0.350
RPL34ZNF320psi-mi:“MI:0914”(association)0.350
RPL27AZNF320psi-mi:“MI:0914”(association)0.350
RPS19ZNF320psi-mi:“MI:0914”(association)0.350
RPL7L1ZNF320psi-mi:“MI:0914”(association)0.350
PURGZNF320psi-mi:“MI:0914”(association)0.350
ZNF467ZNF320psi-mi:“MI:0914”(association)0.350
FBLN5ZNF320psi-mi:“MI:0914”(association)0.350
ZKSCAN8ZNF320psi-mi:“MI:0914”(association)0.350
GOLGA8AZNF320psi-mi:“MI:0914”(association)0.350
NOP2ZNF320psi-mi:“MI:0914”(association)0.350
NOTCH2ZNF320psi-mi:“MI:0914”(association)0.350
ZNF460ZNF320psi-mi:“MI:0914”(association)0.350
LTBP2ZNF320psi-mi:“MI:0914”(association)0.350
SPANXN2ZNF320psi-mi:“MI:0914”(association)0.350
ZNF677ZNF320psi-mi:“MI:0914”(association)0.350
TIMM50ZNF320psi-mi:“MI:0914”(association)0.350
RPLP0ZNF320psi-mi:“MI:0914”(association)0.350
RBM4BZNF320psi-mi:“MI:0914”(association)0.350
RPL4ZNF320psi-mi:“MI:0914”(association)0.350

BioGRID (29): KRTAP10-7 (Two-hybrid), KRTAP10-5 (Two-hybrid), ZNF320 (Affinity Capture-MS), ZNF320 (Affinity Capture-MS), ZNF320 (Affinity Capture-MS), ZNF320 (Affinity Capture-MS), ZNF320 (Affinity Capture-MS), ZNF320 (Affinity Capture-MS), ZNF320 (Affinity Capture-MS), ZNF320 (Affinity Capture-MS), ZNF320 (Affinity Capture-MS), ZNF320 (Affinity Capture-MS), ZNF320 (Affinity Capture-MS), ZNF320 (Affinity Capture-MS), ZNF320 (Affinity Capture-MS)

ESM2 similar proteins: A0A1W2PQL4, A0JPL0, A2RRD8, A6NHJ4, A6NP11, B4DX44, O75346, O95780, P0CB33, P21506, P51508, P52738, Q0D2J5, Q0VGE8, Q12901, Q13360, Q14593, Q15973, Q2M218, Q2M3X9, Q2VY69, Q3SXZ3, Q5HY98, Q5RCJ2, Q5VIY5, Q6J6I6, Q7L2R6, Q86XU0, Q86Y25, Q8IW36, Q8IYN0, Q8IYX0, Q8N782, Q8N883, Q8N9Z0, Q8NDP4, Q95K49, Q969W8, Q96H40, Q96N58

Diamond homologs: A0A1W2PQL4, A2RRD8, A2VDQ7, A6NHJ4, A6NK75, A6NN14, A6NNF4, A6NP11, B4DX44, B4DXR9, E9PW05, O14628, O43345, O75290, O75346, O75373, O75820, P0CB33, P0CJ79, P0DKX0, P10755, P17032, P17035, P52738, Q02386, Q03923, Q03936, Q05481, Q08AN1, Q09FC8, Q0VGE8, Q14586, Q14593, Q147U1, Q15928, Q3MIS6, Q3SXZ3, Q494X3, Q4R6C2, Q5HY98

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 23 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Peptide chain elongation537.3×3e-06
Viral mRNA Translation537.3×3e-06
PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA536.9×3e-06
Selenocysteine synthesis535.4×3e-06
Eukaryotic Translation Termination535.4×3e-06
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)534.6×3e-06
ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA534.6×3e-06
Formation of a pool of free 40S subunits532.9×3e-06

GO biological processes:

GO termPartnersFoldFDR
cytoplasmic translation546.3×8e-06
translation525.7×7e-05

Disease & clinical

Clinical variants and AI predictions

ClinVar

74 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance58
Likely benign4
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1237 predictions. Top by Δscore:

VariantEffectΔscore
19:52881981:TAT:Tacceptor_gain1.0000
19:52888119:AT:Adonor_gain1.0000
19:52888249:AGACC:Aacceptor_gain1.0000
19:52888250:GACC:Gacceptor_gain1.0000
19:52888252:CC:Cacceptor_gain1.0000
19:52888253:CC:Cacceptor_gain1.0000
19:52888253:CCT:Cacceptor_loss1.0000
19:52888254:C:CCacceptor_gain1.0000
19:52888254:C:Tacceptor_gain1.0000
19:52888254:CTG:Cacceptor_loss1.0000
19:52888254:CTGAA:Cacceptor_loss1.0000
19:52888255:T:Cacceptor_loss1.0000
19:52890237:TCA:Tdonor_loss1.0000
19:52890238:CA:Cdonor_loss1.0000
19:52890240:C:CGdonor_loss1.0000
19:52890324:CAATC:Cacceptor_gain1.0000
19:52890327:TC:Tacceptor_gain1.0000
19:52890328:CC:Cacceptor_gain1.0000
19:52890329:CTAA:Cacceptor_loss1.0000
19:52890330:T:Gacceptor_loss1.0000
19:52881979:GATAT:Gacceptor_gain0.9900
19:52881984:C:CCacceptor_gain0.9900
19:52881985:T:Gacceptor_loss0.9900
19:52888097:T:TAdonor_gain0.9900
19:52888098:C:Adonor_gain0.9900
19:52888121:CCTCA:Cdonor_loss0.9900
19:52888122:CTCAC:Cdonor_loss0.9900
19:52888123:TCA:Tdonor_loss0.9900
19:52888124:C:CCdonor_loss0.9900
19:52888125:A:ACdonor_gain0.9900

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000047732 (19:52899683 G>A), RS1000188425 (19:52894365 CAG>C), RS1000220927 (19:52894618 A>T), RS1000280717 (19:52859069 A>G), RS1000523924 (19:52895805 G>T), RS1000554677 (19:52902887 A>C), RS1000555241 (19:52896098 T>C), RS1000568923 (19:52859582 G>A), RS1000606656 (19:52901421 G>A,T), RS1000646951 (19:52897272 C>A), RS1000648066 (19:52860017 A>G), RS1000772864 (19:52864314 A>G), RS1000832948 (19:52889709 A>G,T), RS1000861766 (19:52892668 A>G), RS1000904920 (19:52902491 C>G,T)

Disease associations

OMIM: gene MIM:606427 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

3 associations (top):

StudyTraitp-value
GCST001282_3Psychosis in Alzheimer’s disease5.000000e-06
GCST90002393_671Monocyte count2.000000e-12
GCST90002400_96Plateletcrit4.000000e-13

EFO canonical traits (3, from GWAS)

EFO IDTrait name
EFO:0005940psychotic symptoms
EFO:0005091monocyte count
EFO:0007985platelet crit

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

28 total (human), top 28 by PubMed support.

ChemicalActions (top 5)PubMed papers
sodium arsenitedecreases expression, affects cotreatment, increases abundance, increases expression2
Air Pollutantsaffects expression, increases abundance, decreases expression2
Endosulfandecreases expression, increases expression2
Aflatoxin B1increases methylation2
Particulate Matterdecreases expression, increases abundance, increases expression2
3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamidedecreases expression1
tris(2-butoxyethyl) phosphateaffects expression1
manganese chlorideaffects cotreatment, increases abundance, increases expression1
potassium chromate(VI)increases expression1
di-n-butylphosphoric acidaffects expression1
Resveratrolaffects cotreatment, increases expression1
Acetaminophendecreases expression1
Arbutindecreases expression1
Arsenicincreases expression, affects cotreatment, increases abundance1
Vehicle Emissionsincreases abundance, increases expression1
Benzo(a)pyrenedecreases methylation1
Cadmiumincreases abundance, increases expression1
Doxorubicindecreases expression1
Manganeseaffects cotreatment, increases abundance, increases expression1
Ozoneaffects expression, increases abundance1
Plant Extractsaffects cotreatment, increases expression1
Polychlorinated Biphenylsaffects expression1
Testosteronedecreases expression1
Tobacco Smoke Pollutiondecreases expression1
Vanadatesdecreases expression1
Aflatoxin M1decreases expression1
Asbestos, Crocidolitedecreases expression1
Cadmium Chlorideincreases abundance, increases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.